Table A2.
Univariate analysis between 6-minute walk distance and the non-insulin-dependent diabetes mellitus patients’ group data
| Females (n = 45) | Males (n = 55) | Total sample (n = 100) | |
|---|---|---|---|
| Smoking status, medical, surgical, and obstetric history | |||
| Cigarette use | |||
| Yes | Not done | 595 ± 59 | 597 ± 59 |
| No | 637 ± 75* | 547 ± 86* | |
| Narghile use | |||
| Yes | Not done | 608 ± 69 | 616 ± 54 |
| No | 616 ± 54 | 562 ± 81 | |
| Chronic respiratory diseases | |||
| Yes | 562 ± 31 | 588 ± 46 | 580 ± 42 |
| No | 510 ± 64 | 612 ± 69 | 564 ± 84 |
| Arterial hypertension | |||
| Yes | 521 ± 42 | 587 ± 53 | 551 ± 58 |
| No | 507 ± 76 | 619 ± 71 | 574 ± 91 |
| Dyslipidemia | |||
| Yes | 514 ± 69 | 607 ± 86 | 554 ± 88 |
| No | 513 ± 63 | 609 ± 65 | 568 ± 80 |
| Cardiovascular diseases | |||
| Yes | 471 ± 96 | 571 ± 91 | 528 ± 100 |
| No | 516 ± 61 | 612 ± 65 | 569 ± 79 |
| Dysthyroid | |||
| Yes | 537 ± 15 | Not done | 537 ± 15 |
| No | 511 ± 66 | 567 ± 82 | |
| Diabetic retinopathy | |||
| Yes | 461 ± 101 | 577 ± 47 | 534 ± 88 |
| No | 577 ± 60 | 612 ± 68 | 569 ± 80 |
| Surgical history | |||
| Yes | 497 ± 69 | 595 ± 69 | 528 ± 82 |
| No | 523 ± 52 | 611 ± 67 | 578 ± 25* |
| Parity | |||
| Low | 528 ± 52 | ||
| High | 467 ± 74* | ||
| Medication use | |||
| Beta-blocker use | |||
| Yes | 491 ± 66 | 593 ± 43 | 532 ± 76 |
| No | 517 ± 63 | 610 ± 69 | 570 ± 81 |
| Diuretic use | |||
| Yes | 551 ± 43 | Not done | 571 ± 54 |
| No | 511 ± 64 | 566 ± 82 | |
| Socioeconomic, schooling, and physical activity levels | |||
| Socioeconomic level | |||
| Low | 497 ± 66 | 590 ± 50 | 520 ± 74 |
| High | 539 ± 52* | 613 ± 70 | 592 ± 73* |
| Schooling level | |||
| Low | 494 ± 65 | 601 ± 50 | 537 ± 80 |
| High | 532 ± 56* | 612 ± 73 | 583 ± 77* |
| Physical activity level | |||
| Sedentary | 502 ± 62 | 616 ± 71 | 543 ± 69 |
| Active | 542 ± 59 | 605 ± 66 | 589 ± 69* |
| Metabolic characteristics | |||
| Obesity | |||
| Yes | 511 ± 57 | 584 ± 47 | 537 ± 64 |
| No | 518 ± 78 | 620 ± 72 | 592 ± 86* |
| Uncontrolled diabetes | |||
| Yes | 504 ± 74 | 606 ± 64 | 562 ± 85 |
| No | 515 ± 47 | 613 ± 73 | 571 ± 75 |
| Measured dyslipidemia | |||
| Yes | 511 ± 58 | 610 ± 76 | 565 ± 84 |
| No | 519 ± 75 | 608 ± 47 | 567 ± 75 |
| Anthropometric data and parity | |||
| Age (years) | −0.54** | −0.25** | −0,34** |
| Weight (kg) | 0.09 | −0.10 | 0.03 |
| Height (m) | 0.24 | 0.20 | 0.57** |
| Body mass index (kg/m2) | 0.02 | −0.22 | −0.31** |
| Parity (numerical) | −0.44** | ||
| Metabolic data | |||
| Fasting glycemia (mmol/L) | 0.05 | −0.03 | 0.01 |
| Glycated hemoglobin (%) | −0.16 | 0.06 | 0.01 |
| Triglycerides (mmol/L) | −0.04 | 0.09 | 0.13 |
| Total cholesterol (mmol/L) | 0.01 | 0.23 | 0.01 |
| HDL-cholesterol (mmol/L) | −0.08 | 0.16 | 0.03 |
| LDL-cholesterol (mmol/L) | 0.04 | 0.09 | −0.09 |
| Physical activity and absolute cardiovascular disease risk (ACVDR) scores | |||
| Activities | |||
| Daily | −0.11 | 0.02 | −0.36** |
| Sporting | 0.16 | −0.18 | 0.19** |
| Leisure | 0.07 | 0.28** | 0.31** |
| Physical | 0.15 | −0.05 | 0.24** |
| ACVDR score | 0.04 | −0.28** | 0.21** |
| 6MWT resting data | |||
| Dyspnea (VAS) | 0.23 | −0.21 | −0.05 |
| Heart rate (bpm) | 0.29** | −0.17 | −0.04 |
| Systolic pressure (mmHg) | −0.04 | −0.30** | −0.20** |
| Diastolic pressure (mmHg) | 0.25 | −0.21 | −0.01 |
| Oxy-sat (%) | 0.18 | 0.29** | 0.21** |
Notes: Data are expressed in means ± standard deviation;
*
P (probability, t-test) < 0.05;
**
P (coefficient of correlation) < 0.05.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; 6MWT, 6-minute walk test; VAS, visual analog scale; bpm, beats per minute; oxy-sat, oxyhemoglobin saturation.